Vaccine · BLA
Arexvy NDC 58160-848
respiratory syncytial virus vaccine recombinant, adjuvanted · Kit · GlaxoSmithKline Biologicals SA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58160-848-11 | 58160084811 | 1 KIT in 1 CARTON (58160-848-11) * .5 mL in 1 VIAL (58160-723-03) * .5 mL in 1 VIAL (58160-744-03)Marketed from May 3, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Arexvy
- Generic name (nonproprietary)
- respiratory syncytial virus vaccine recombinant, adjuvanted
- Dosage form
- Kit
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125775
- Marketing start
- Listing expires
- Identifiers
- Product ID 58160-848_ed295307-eb7c-42c3-80a2-080a316c8954SPL ID ed295307-eb7c-42c3-80a2-080a316c8954
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N458160084811followed by a unit qualifier and the quantityPackage 58160-0848-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
Other NDCs under BLA 125775
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-894 |
| Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-882 |